Showing results (1681-1690 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|February 5, 2013
Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledgeJanusz K RybakowskiCNS Drugs|February 26, 2013
Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studiesJerome Sarris, Erica McIntyre, David A CamfieldCNS Drugs|March 7, 2013
Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory studyAnn-Sofie M E Ingels, Katrien B Hertegonne, Willy E Lambert, et al.CNS Drugs|February 3, 2012
Depression following traumatic brain injury: epidemiology, risk factors and managementMark J RapoportCNS Drugs|February 3, 2012
The role of antipsychotics in the management of fibromyalgiaElena P Calandre, Fernando Rico-VillademorosCNS Drugs|May 31, 2013
Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidenceJessica Freiherr, Manfred Hallschmid, William H Frey, et al.CNS Drugs|June 5, 2013
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitorsGeorge T Grossberg, Facundo Manes, Ricardo F Allegri, et al.CNS Drugs|June 13, 2013
Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchPau Celada, Analía Bortolozzi, Francesc ArtigasCNS Drugs|June 18, 2013
Causes of CNS inflammation and potential targets for anticonvulsantsMercé Falip, Xavier Salas-Puig, Carlos CaraCNS Drugs|June 20, 2013
Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspectiveAnna-Sophia Rauch, W Wolfgang FleischhackerPageof 211